Patient-Focused Drug Development

Learn how people with MS are shaping the clinical trials for future MS drugs. A recent collaboration between iConquerMS and EMD Serono helped ensure that the perspectives of people with MS were meaningfully incorporated into the design and implementation of a trial for evobrutinib, an investigational drug for MS.

Publication Date: 
Wednesday, October 14, 2020